Member Info for RuckRover

Crumbs,
"Who needs Pfizer or Phizzer when you can become bigger than them :)"
Well it's only taken them 172 years to get where they are. I guess patience is really the key here then?

Well a new breed of anti-vaxxers - only anti-vax unless it is by the company they happen to be invested in!
Isn't that a bit mercenary?

ananda,

No vaccine will stop you getting infected. The only way the vaccine is able to have an effect is when you DO get infected.
If the vaccine works, you will fight off the infection and be infected and infectious for a shorter period.

I think you need to calm down a bit!

"Biontech became worth billions with what appears to be a vastly inferior vaccine."

My rampometer just gone off the scale!
I have to agree with crumbs you can't describe an approved, on the market vaccine with a 94% efficacy as "vastly inferior" to one not yet tested on a single human. Perhaps, when it is approved and on the market and we get some efficacy data we may be able to describe it as "slightly better" or "complimentary".

Max,
Your 09:55 - very well put.

Perhaps LD is seen as the Ugur Sahin of Scancell. He is the company founder, CEO and both voice and face of BioNtech.
No matter how brilliant you are in your field, there comes a realisation that you can achieve much more through others. I suspect over the past few years, LD has trained and mentored an elite few to take up the hands on work and has taken on an increasing managerial role for herself (in both her university and Scancell positions)

I'm impressed, been in the job less than 24 hours and got the SA trial approved. Keep it up.

Lol.
He gets his second stab in four weeks time.

" the obvious questons being why so suddenly."

Spot on C7.
The unexpected and sudden nature seems to have rattled a few here!

Let's hope we get some further information soon. As others have suggested, I think an interview with LD would be welcome, let's see what she has to say for herself,

Bermuda,
You are spot on as always. At a time when investors have been in a news vacuum for months, hoping for, expecting even news on the SCOV trials in SA, the SCIB1 combo trials, the MODI1 submission we get an after hours RNS stating the current CEO is stepping down (surprising enough) and the new CEO will be the current, part time CSO (even more surprising)

Not too fussed about CH going but a few concerns about the new CEO role. Given tha LD is only part time (let's assume 50%) does that mean we have 25% of a CEO and 25% Of a CSO?

There are more questions than answers and I agree, the whole saga has been handled badly. Let's hope we get some clarification soon.

WTP,

I'd say Scancell are very much still a "baby" bio. They rely on their parents (Redmile/Vulpes) for financial support as they are unable to stand on their own two feet at the moment. Perhaps they will never grow up, like Peter Pan?

And like real kids, they can get through mum and dad's money a a fair rate of knots lol!

Chelsea,
I'd say it was more "sluggish" than snail-like.

I'll get my coat...

AB,
If Redmile opposed the takeover they could use the CLNs to their advantage. If they agreed to a takeover there would be an agreement to repay plus interest.
Not really an issue unless things got nasty.

AB,
No, I'm talking about a deal before conversion. The bid would be on the basis they were taking on the debt and repaying it.

AB,
The balance of power is interesting - PIs are the largest group of holders at 48%. So if we agreed to a 50p takeover, we would only need support from one other group, either Redmile, Vulpes, Calculus or the BOD.
If Redmile wanted to vote it down, they would need support from everyone else (other than PIs.)
I think if it came to it, the PI vote would be split. I think many (half?) would be happy to see 50p but there are still plenty who dream of ££££s. I remember a DE comment when he said back in 2012 they thought £3 was possible - then reality set in! That reality doesn't seemed to have permeated through to everyone.
I think a low-ball bid of 60-70p could generate a fair bit of support from various parties.
Anyway, if we get some news tomorrow it could squash all this speculation.
AIMO

Crumbs,

I know we've disagreed on this before so don't want to make a big deal out of it, but...
"I know Lindy knows the value of her platforms and is not going to be giving anything away"

I'm sure Prof Durrant is well aware of the scientific value and medical potential but as to commercial value, perhaps not. In fact there's probably no one on the BOD who truly knows the worth. I suspect that given their walking away from deals, they have a rather inflated view of the value. I would think the only one with an accurate and realistic view is Redmile. They will have an assessment for what it is worth now as a job lot (pretty low), what it will be worth in 18 months time with good/bad/indifferent results.

Also, does anyone know what % are needed to accept an offer - is it over 50% or something higher?

AB,
What do you think a realistic low-ball bid would be? One that was acceptable to the BOD and PI's?

"hopefully, we get to see that vid and or an update tommaz from the OXT event"
Crumbs,
I hope so too. But I find it incredulous that a company holding 1% of the shares is given this sort of preference over us private investors who hold 48% of the company!

Ray,
Increasing the IP isn't a problem, only if it distracts attention/focus away from priority tasks.

Moon,
I'm not suggesting the top three are run in series at all - they should be run in parallel, possibly slightly staggered?

Ray,
Of course it's valid - it's about FOCUS. You have to prioritise on the things that you can do best/quickest/within budget.
The problem is Scancell are far better at scientific research than they are at commercialisation. This means, they will be constantly discovering new distractions and could well end up not bringing any of them to fruition.

My builder had it right. He bought an old farm and outbuilding. He built a barn conversion and sold it at cost (recouping some of the land spend). He used the money to build a second house and sold it at a small profit. He then build four more barn conversions and made good money (mine being one of them!)

I'm not suggesting for one moment that anyone sits twiddling their thumbs - let them get on with it, but the management and research priority and FOCUS has to be on commercialising SOMETHING.

What we need is a Steve Jobs and CH isn't one.